D.E. Shaw & Co
SLGCW

D.E. Shaw & Co’s SomaLogic, Inc. Warrant SLGCW Stock Holding History

D.E. Shaw & Co’s Portfolio SLGCW Stock Details SLGCW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-990,303
Closed -$119K – 4909
2023
Q4 		$119K Buy
990,303
+600,000
+154% +$85.5K ﹤0.01% 3952
2023
Q3 		$85.9K Hold
390,303
– – ﹤0.01% 3872
2023
Q2 		$97.6K Hold
390,303
– – ﹤0.01% 3833
2023
Q1 		$105K Hold
390,303
– – ﹤0.01% 3974
2022
Q4 		$156K Buy
390,303
+129,178
+49% +$51.4K ﹤0.01% 4302
2022
Q3 		$115K Buy
261,125
+149,028
+133% +$99.2K ﹤0.01% 4578
2022
Q2 		$85K Buy
112,097
+3,378
+3% +$3.84K ﹤0.01% 4761
2022
Q1 		$222K Buy
108,719
+2,247
+2% +$5.44K ﹤0.01% 4814
2021
Q4 		$358K Hold
106,472
– – ﹤0.01% 4590
2021
Q3 		$367K Buy
+106,472
New +$328K ﹤0.01% 4250

Other funds holding SLGCW

GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

D.E. Shaw & Co's SLGCW Position: Q1 2024 in Review

D.E. Shaw & Co sold out of SomaLogic, Inc. Warrant (SLGCW) in Q1 2024, closing a stake of 990,303 shares — an estimated $119K sold.

D.E. Shaw & Co first reported a position in SLGCW in Q3 2021 and held it in 10 quarters. The position peaked at $367K in Q3 2021. 4 funds tracked by Wall St. Rank hold SLGCW as of Q1 2024.

  • D.E. Shaw & Co reported no remaining SomaLogic, Inc. Warrant position as of Q1 2024 after selling out during the quarter.
  • D.E. Shaw & Co sold 990,303 SomaLogic, Inc. Warrant shares in Q1 2024, an estimated $119K.
  • D.E. Shaw & Co first reported a position in SomaLogic, Inc. Warrant in Q3 2021 and held it in 10 quarters.
  • D.E. Shaw & Co's SomaLogic, Inc. Warrant position peaked at $367K in Q3 2021.
  • 4 funds tracked by Wall St. Rank held SomaLogic, Inc. Warrant as of Q1 2024.

Based on D.E. Shaw & Co's 13F filing for Q1 2024, filed 15 May 2024.